{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:19:07Z","timestamp":1776781147308,"version":"3.51.2"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.anndiagpath.2021.151722","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T21:13:20Z","timestamp":1612991600000},"page":"151722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer"],"prefix":"10.1016","volume":"52","author":[{"given":"Vivek","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prerna","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajakta","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151722_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0010","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1242\/jcs.010389","article-title":"The RASSF1A tumor suppressor","volume":"120","author":"Donninger","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0015","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.3390\/ijms18102160","article-title":"Impact of natural compounds on DNA methylation levels of the tumor suppressor gene RASSF1A in cancer","volume":"18","author":"Dammann","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0020","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4161\/cbt.4.10.2023","article-title":"High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma","volume":"4","author":"Pan","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4161\/epi.27956","article-title":"Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism","volume":"9","author":"Coppede","year":"2014","journal-title":"Epigenetics."},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0030","series-title":"Molecular cloning: a laboratory manual","first-page":"64","article-title":"Isolation and quantification of DNA","year":"2012"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0035","series-title":"Manual. Catalog nos. D5002","first-page":"1","author":"EZ DNA Methylation\u2122 Kit","year":"2019"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0040","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1080\/15384101.2015.1035845","article-title":"Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks","volume":"14","author":"Pefani","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2009.10.011","article-title":"Epigenetics and cancer treatment","volume":"625","author":"Kristensen","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.onc.1206057","article-title":"Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients","volume":"22","author":"Honorio","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0055","first-page":"1630","article-title":"Association of aberrant DNA methylation with clinicopathological features in breast cancer","volume":"27","author":"Tserga","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1593\/tlo.13244","article-title":"RASSF1A promoter methylation levels positively correlate with estrogen receptor expression in breast cancer patients","volume":"6","author":"Kajabova","year":"2013","journal-title":"Transl Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0065","series-title":"Cancer epigenetics","first-page":"79","article-title":"Role of DNA methylation in cancer progression","author":"Choi","year":"2009"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.11613\/BM.2015.017","article-title":"Aberrant methylation patterns in cancer: a clinical view","volume":"25","author":"Paska","year":"2015","journal-title":"Biochem Med"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151722_bb0075","first-page":"1887","article-title":"Methylation profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese women with breast cancer","volume":"19","author":"Vu","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1200\/JGO.2016.005397","article-title":"Prevalence of triple negative breast cancer in India: systematic review and meta-analysis","volume":"2","author":"Sandhu","year":"2016","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151722_bb0085","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1038\/sj.onc.1206651","article-title":"Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples","volume":"22","author":"Waki","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151722_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00313020500058623","article-title":"High frequency of promoter hypermethylation of RASSF1A in tumorous and non-tumourous tissue of breast cancer","volume":"34","author":"Yea","year":"2005","journal-title":"Pathology."}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:08Z","timestamp":1761078728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":18,"alternative-id":["S1092913421000228"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151722","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151722"}}